ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983

Data collection Completed In NCI Study of BRACA1

August 16, 1996

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000